Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    Septo-Optic Dysplasia
Show Display Options
Download search resultsDownload the search results for:
Septo-Optic Dysplasia (2 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
Conditions: Growth Hormone Deficiency;   Septo-Optic Dysplasia;   Hypopituitarism
Intervention: Drug: Nutropin AQ
2 Unknown  Biological Clock Dysfunction in Optic Nerve Hypoplasia
Conditions: Biological Clock Dysfunction;   Optic Nerve Hypoplasia
Interventions: Dietary Supplement: Melatonin;   Dietary Supplement: Placebo Comparator

Indicates status has not been verified in more than two years